Rahul Dhanda is the founder of Syntis Bio. Syntis Bio has raised $87M in total funding. Latest round: Series A. Based in Boston, United States.
Rahul Dhanda is the co-founder, president, and CEO of Syntis Bio, a clinical-stage biopharmaceutical company focused on developing oral therapies for obesity, diabetes, and rare diseases. He founded the company and led the oversubscribed first closing of its seed round.
Full founder directory · Investor directory · Company funding database · Fundraising library